Kura Oncology Inc (KURA)

SG&A Expenses

$134.93M

TTM · Period ending: · USD

KURA logo

KURA SG&A Expenses

Latest reported$134.93M
KURA TTM SG&A Expenses ($20.51K → $134.93M)
High-resolution chart · PNG

KURA sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Kura Oncology Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
134,928,000
128,347,000
119,982,000
104,914,000
90,254,000
81,560,000
76,675,000
66,619,000
61,369,000
56,715,000
50,139,000
48,612,000
47,304,000
46,558,000
47,053,000
46,647,000
46,336,000
47,834,000
46,537,000
43,263,000
39,546,000
34,449,000
31,502,000
28,193,000
25,734,000
22,709,000
19,653,000
18,704,000
17,891,000
17,240,000
16,096,000
14,422,000
12,458,000
10,936,000
9,651,000
8,750,000
8,135,000
7,712,000
7,963,000
7,717,000
7,768,000
7,419,000
6,088,000
4,367,589
2,637,589
1,136,831
80,969
80,074
21,549
21,763
22,341
24,122
24,375
23,915
23,440
19,010
19,642
24,750
24,775
26,944
25,822
20,839
20,509
28,908
28,215
23,094
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.